Herbas VPB

Print
EN | LT
LT - 2-(2,4,5-Pakeistieji-anilino)pirimidino dariniai kaip EGFR moduliatoriai, naudingi vėžio gydymui
EN - 2-(2,4,5-SUBSTITUTED-ANILINO)PYRIMIDINE DERIVATIVES AS EGFR MODULATORS USEFUL FOR TREATING CANCER

Legal status

Patent in force

Claims | Licences
Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07D 401/02 (2006.01)
C07D 471/04 (2006.01)
A61K 31/506 (2006.01)
A61K 31/437 (2006.01)
A61P 35/00 (2006.01)
European patent
(11) Number of the document 3333161
(13) Kind of document T
(96) European patent application number 17194307.9
Date of filing the European patent application 2012-07-25
(97) Date of publication of the European application 2018-06-13
(45) Date of publication and mention of the grant of the patent 2020-02-19
(46) Date of publication of the claims translation 2020-05-11
Priority applications
(30) Number Date Country code
201161512061 P 2011-07-27 US
201261591363 P 2012-01-27 US
Inventors
(72)
BUTTERWORTH, Sam, GB
WARD, Richard, Andrew, GB
FINLAY, Maurice, Raymond, Verschoyle, GB
KADAMBAR, Vasantha, Krishna, GB
CHINTAKUNTLA, Chandrasekhara, Reddy, GB
MURUGAN, Andiappan, GB
CHUAQUI, Claudio, Edmundo, US
REDFEARN, Heather, Marie, GB
Grantee
(73) Astrazeneca AB, 151 85 Södertälje, SE
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) 2-(2,4,5-Pakeistieji-anilino)pirimidino dariniai kaip EGFR moduliatoriai, naudingi vėžio gydymui
  2-(2,4,5-SUBSTITUTED-ANILINO)PYRIMIDINE DERIVATIVES AS EGFR MODULATORS USEFUL FOR TREATING CANCER
Last renewal fee
Payment date Validity (years) Amount
2025-06-19 14 289.00 EUR
Next renewal fee
2026-07-25
Last update date 2025-06-21